drugset / Trial / NCT03180463

The Study of Early Stage Osteonecrosis of Femoral Head With Human Umbilical Cord Mesenchymal Stem Cells (19#iSCLife®-ONFH)

NCT03180463

Phase 1/2 Suspended 30 enrolled Sclnow Biotechnology Co., Ltd.
RandomizedParallel-groupDouble-blindTreatment

Summary

The purposes of the study is to evaluate the safety and efficacy of human umbilical cord mesenchymal stem cells (hUC-MSC) in treating osteonecrosis of femoral head patients.

Timeline

Start
2026-12-31
Primary completion
2027-06-30
Completion
2027-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject SCLnow 19# Cell therapy 2e+07 cells Other

Indications